Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L-B Zimmerhackl

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 1999
Pharmacokinetics of mycophenolic acid (MPA) and free MPA in paediatric renal transplant recipients--a multicentre study. The German Study Group on Mycophenolate Mofetil (MMF) TherapyL T Weber, E Schütz, T Lamersdorf, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 1999
Therapeutic drug monitoring of total and free mycophenolic acid (MPA) and limited sampling strategy for determination of MPA-AUC in paediatric renal transplant recipients. The German Study Group on Mycophenolate Mofetil (MMF) TherapyL T Weber, E Schütz, T Lamersdorf, et al.
Transplantation Proceedings|June 24, 1998
Limited sampling strategy for the determination of mycophenolic acid area under the curve in pediatric kidney recipients. German Study Group on MMF Therapy in Pediatric Renal Transplant RecipientsE Schütz, V W Armstrong, M Shipkova, et al.
Therapeutic Drug Monitoring|October 16, 1999
Area under the plasma concentration-time curve for total, but not for free, mycophenolic acid increases in the stable phase after renal transplantation: a longitudinal study in pediatric patients. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant RecipientsL T Weber, T Lamersdorf, M Shipkova, et al.
Journal of the American Society of Nephrology : JASN|August 11, 1998
Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German Study group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant RecipientsL T Weber, M Shipkova, T Lamersdorf, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|August 24, 2006
[Surveillance of infectious foodborne diseases after enactment of the German Protection against Infection Act in 2001. Potentials and requirements]D Werber, M H Kramer, U Buchholz, et al.
Transplantation Proceedings|September 25, 2002
Prevalence of arterial hypertension and its morbidity in children and adolescents 3 years after renal transplantation with mycophenolate mofetil-based immunosuppressionT Jungraithmayr, A Staskewitz, G Kirste, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 18, 2012
Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndromeJohannes Hofer, Andreas R Janecke, L B Zimmerhackl, et al.
Pediatric Nephrology (Berlin, Germany)|January 17, 2002
The use of mycophenolate mofetil suspension in pediatric renal allograft recipientsT Bunchman, M Navarro, M Broyer, et al.
The New England Journal of Medicine|June 7, 2013
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndromeC M Legendre, C Licht, P Muus, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 1999
Pharmacokinetics of mycophenolic acid (MPA) and free MPA in paediatric renal transplant recipients--a multicentre study. The German Study Group on Mycophenolate Mofetil (MMF) TherapyL T Weber, E Schütz, T Lamersdorf, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 1999
Therapeutic drug monitoring of total and free mycophenolic acid (MPA) and limited sampling strategy for determination of MPA-AUC in paediatric renal transplant recipients. The German Study Group on Mycophenolate Mofetil (MMF) TherapyL T Weber, E Schütz, T Lamersdorf, et al.
Transplantation Proceedings|June 24, 1998
Limited sampling strategy for the determination of mycophenolic acid area under the curve in pediatric kidney recipients. German Study Group on MMF Therapy in Pediatric Renal Transplant RecipientsE Schütz, V W Armstrong, M Shipkova, et al.
Therapeutic Drug Monitoring|October 16, 1999
Area under the plasma concentration-time curve for total, but not for free, mycophenolic acid increases in the stable phase after renal transplantation: a longitudinal study in pediatric patients. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant RecipientsL T Weber, T Lamersdorf, M Shipkova, et al.
Journal of the American Society of Nephrology : JASN|August 11, 1998
Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German Study group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant RecipientsL T Weber, M Shipkova, T Lamersdorf, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|August 24, 2006
[Surveillance of infectious foodborne diseases after enactment of the German Protection against Infection Act in 2001. Potentials and requirements]D Werber, M H Kramer, U Buchholz, et al.
Transplantation Proceedings|September 25, 2002
Prevalence of arterial hypertension and its morbidity in children and adolescents 3 years after renal transplantation with mycophenolate mofetil-based immunosuppressionT Jungraithmayr, A Staskewitz, G Kirste, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 18, 2012
Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndromeJohannes Hofer, Andreas R Janecke, L B Zimmerhackl, et al.
Pediatric Nephrology (Berlin, Germany)|January 17, 2002
The use of mycophenolate mofetil suspension in pediatric renal allograft recipientsT Bunchman, M Navarro, M Broyer, et al.
The New England Journal of Medicine|June 7, 2013
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndromeC M Legendre, C Licht, P Muus, et al.
Pageof 7